Menu

Gritstone bio, Inc. GRTS

Full chart Compare
Set alert

Price alert · GRTS

All alert types
0.03 USD -0.02 (-31.78%)

At closeOct 21, 2024, 4:00 PM EDT

0.031 Day range 0.0403
0.03 52-week range 3.17
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Other Income → Expenses: $16.14MExpenses → Gross Loss: $6.26MExpenses → Selling, General & Admin: $21.19MExpenses → Research & Development: $127.18MNet Loss → Expenses: $138.49MRevenue → Cost of Revenue: $1.33MOther Income$16.14MNet Loss$138.49MCost of Revenue$7.59MExpenses$154.63MGross Loss$6.26MSelling, General & Admin$21.19MResearch & Development$127.18MRevenue$1.33M

Latest period ending Dec 31, 2023 · select a line to chart its full history

GRTS annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
16.34M19.95M48.21M4.04M4.37M
16.34M19.95M48.21M4.04M4.37M
-139.65M-120.43M-75.21M-106.02M-97.94M
-138.49M-119.69M-75.08M-105.31M-94.43M
-1.20-1.32-0.95-2.79-2.81
GRTS annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
65.28M59.48M104.57M170.06M57.41M
177.77M240.75M278.11M221.57M184.39M
125.92M69.97M62.02M54.83M50.05M
104.78M40.32M26.42M25.10M23.49M
51.85M170.78M216.09M166.74M134.34M
GRTS annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-121.65M-115.95M-50.68M-89.10M-85.01M
102.34M-12.96M-118.55M65.95M15.84M
25.12M83.10M108.76M135.80M74.39M
-4.57M-5.87M-5.70M-3.52M-16.17M
5.81M-45.81M-60.47M112.65M5.22M